143 related articles for article (PubMed ID: 8880890)
1. Effects of the methyl esters of pyruvate, succinate and glutamate on the secretory response to meglitinide analogues in rat pancreatic islets.
Bakkali Nadi A; Zhang TM; Malaisse WJ
Pharmacol Res; 1996 Mar; 33(3):191-4. PubMed ID: 8880890
[TBL] [Abstract][Full Text] [Related]
2. Insulinotropic action of meglitinide analogs: concentration-response relationship and nutrient dependency.
Bakkali-Nadi A; Malaisse-Lagae F; Malaisse WJ
Diabetes Res; 1994; 27(2):81-7. PubMed ID: 7671557
[TBL] [Abstract][Full Text] [Related]
3. Insulinotropic action of meglitinide analogues: modulation by an activator of ATP-sensitive K+ channels and high extracellular K+ concentrations.
Malaisse WJ
Pharmacol Res; 1995 Sep; 32(3):111-4. PubMed ID: 8745339
[TBL] [Abstract][Full Text] [Related]
4. Glucose-dependent and glucose-sensitizing insulinotropic effect of nateglinide: comparison to sulfonylureas and repaglinide.
Hu S; Wang S; Dunning BE
Int J Exp Diabetes Res; 2001; 2(1):63-72. PubMed ID: 12369728
[TBL] [Abstract][Full Text] [Related]
5. Stimulation of insulin and somatostatin release by two meglitinide analogs.
Leclercq-Meyer V; Ladrière L; Fuhlendorff J; Malaisse WJ
Endocrine; 1997 Dec; 7(3):311-7. PubMed ID: 9657067
[TBL] [Abstract][Full Text] [Related]
6. Effect of repaglinide upon nutrient metabolism, biosynthetic activity, cationic fluxes and insulin release in rat pancreatic islets.
Louchami K; Jijakli H; Sener A; Malaisse WJ
Res Commun Mol Pathol Pharmacol; 1998 Feb; 99(2):155-68. PubMed ID: 9583090
[TBL] [Abstract][Full Text] [Related]
7. [Structures and mechanisms for non SU insulin secretagogues].
Kikuchi M
Nihon Rinsho; 2002 Sep; 60 Suppl 9():362-70. PubMed ID: 12387019
[No Abstract] [Full Text] [Related]
8. Pharmacology of the meglitinide analogs: new treatment options for type 2 diabetes mellitus.
Malaisse WJ
Treat Endocrinol; 2003; 2(6):401-14. PubMed ID: 15981944
[TBL] [Abstract][Full Text] [Related]
9. Interaction of nateglinide with K(ATP) channel in beta-cells underlies its unique insulinotropic action.
Hu S
Eur J Pharmacol; 2002 May; 442(1-2):163-71. PubMed ID: 12020694
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of nateglinide on in vitro insulin secretion from rat pancreatic islets desensitized to sulfonylureas.
Hu S; Wang S; Dunning BE
Int J Exp Diabetes Res; 2001; 2(1):73-9. PubMed ID: 12369729
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of action of a new class of insulin secretagogues.
Malaisse WJ
Exp Clin Endocrinol Diabetes; 1999; 107 Suppl 4():S140-3. PubMed ID: 10522840
[TBL] [Abstract][Full Text] [Related]
12. Stimulation of insulin release by D-glucose in depolarized pancreatic islets.
Malaisse WJ
Cell Signal; 1997; 9(3-4):265-8. PubMed ID: 9218126
[TBL] [Abstract][Full Text] [Related]
13. Long-term effects of glibenclamide and nateglinide upon pancreatic islet function in normal and diabetic rats.
Laghmich A; Ladrière L; Malaisse-Lagae F; Malaisse WJ
Pharmacol Res; 1999 Dec; 40(6):475-82. PubMed ID: 10660944
[TBL] [Abstract][Full Text] [Related]
14. Selectivity of prandial glucose regulators: nateglinide, but not repaglinide, accelerates exocytosis in rat pancreatic A-cells.
Bokvist K; Hoy M; Buschard K; Holst JJ; Thomsen MK; Gromada J
Eur J Pharmacol; 1999 Dec; 386(1):105-11. PubMed ID: 10611470
[TBL] [Abstract][Full Text] [Related]
15. Effect of N-[(trans-4-isopropylcyclohexyl)-carbonyl]-D-phenylalanine on nutrient catabolism in rat pancreatic islets.
Malaisse WJ; Sener A
Gen Pharmacol; 1998 Sep; 31(3):451-4. PubMed ID: 9703218
[TBL] [Abstract][Full Text] [Related]
16. Pancreatic islet response to dicarboxylic acid esters in rats with type 2 diabetes: enzymatic, metabolic and secretory aspects.
Rasschaert J; Giroix MH; Conget I; Mercan D; Leclercq-Meyer V; Sener A; Portha B; Malaisse WJ
J Mol Endocrinol; 1994 Oct; 13(2):209-17. PubMed ID: 7848532
[TBL] [Abstract][Full Text] [Related]
17. Repaglinide preserves nutrient-stimulated biosynthetic activity in rat pancreatic islets.
Viñambres C; Villanueva-Peñacarrillo ML; Valverde I; Malaisse WJ
Pharmacol Res; 1996; 34(1-2):83-5. PubMed ID: 8981561
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic beta-cell K(ATP) channel activity and membrane-binding studies with nateglinide: A comparison with sulfonylureas and repaglinide.
Hu S; Wang S; Fanelli B; Bell PA; Dunning BE; Geisse S; Schmitz R; Boettcher BR
J Pharmacol Exp Ther; 2000 May; 293(2):444-52. PubMed ID: 10773014
[TBL] [Abstract][Full Text] [Related]
19. Effect of insulinotropic agent nateglinide on Kv and Ca(2+) channels in pancreatic beta-cell.
Hu S; Wang S
Eur J Pharmacol; 2001 Sep; 427(2):97-104. PubMed ID: 11557260
[TBL] [Abstract][Full Text] [Related]
20. Effect of repaglinide on insulin secretion in islets from rats infused for two days with a hypertonic solution of D-glucose.
Louchami K; Ladrière L; Jijakli H; Malaisse WJ
Endocrine; 1998 Jun; 8(3):247-50. PubMed ID: 9741829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
